Biotechnology

Filter

Current filters:

None

Popular Filters

1930 to 1954 of 2293 results

Health activists call for greater public return on EU health R&D spending and a turn to needs-driven innovation

18-04-2012

In a Policy Paper published yesterday, Health Action International (HAI) Europe and the Trans Atlantic…

BiotechnologyEuropeFinancialPharmaceuticalResearch

Australian Biotech industry confident, despite economic woes

18-04-2012

The annual Biotechnology Industry Position Survey shows the bullish sentiment for the Australian industry's…

Asia-PacificBiotechnologyFinancialResearch

Towards a robust global framework for conduct and oversight of clinical trials in EU

18-04-2012

The European Medicines Agency has published the final reflection paper on ethical and good clinical practice…

BiotechnologyEuropePharmaceuticalRegulationResearch

Daiichi Sankyo debuts bone cancer drug Ranmark in Japan

17-04-2012

Following National Health Insurance price listing yesterday, Japanese drug major Daiichi Sankyo (TYO:…

AmgenAsia-PacificAstraZenecaBiotechnologyDaiichi SankyodenosumabMarkets & MarketingOncologyPharmaceuticalRanmark

ImmunoGen IND for IMGN853 now active; IMGN529 trial commenced

17-04-2012

US biotechnology firm ImmunoGen (Nasdaq: IMGN) says that the Investigational New Drug (IND) application…

BiotechnologyImmunoGenOncologyResearch

Drug shortages spur developments in neurometabolic treatments

17-04-2012

A prolonged gap in the neurology market following the shutdown of a Genzyme production facility is tempting…

BiotechnologyMarkets & MarketingNeurologicalPharmaceuticalRare diseasesResearch

Merck & Co in potential $1 billion deal for cancer drug candidate vintafolide

17-04-2012

US drug giant Merck & Co (NYSE: MRK) has entered into an agreement to develop and commercialize Endocyte's…

BiotechnologyEndocyteetarfolatideLicensingMerck & CoOncologyPharmaceuticalvintafolide

Halozyme plunges as FDA call for more data on HyQ BLA

17-04-2012

USA-based Halozyme Therapeutics saw its shares plummet 24% to $8.56 by close of trading yesterday, after…

Baxter InternationalBiotechnologyHalozyme TherapeuticsHyQImmunologicalsNorth AmericaRegulation

Deal-making opportunities for big pharma and biotech firms

15-04-2012

Big pharmaceutical companies are looking to partner with biotechnology companies for the innovation required…

AmgenAstraZenecaBiotechnologyLicensingPharmaceutical

Investment on R&D by research-based Pharma in USA dips to $49.5 billion

13-04-2012

As the research-based pharmaceutical industry in the USA adapts to the challenges of evolving science,…

BiotechnologyFinancialNorth AmericaPharmaceuticalResearch

Lonza and Agennix link up for talactoferrin production

12-04-2012

Switzerland-based Lonza (SIX: LONN) and Agennix AG (FSE: AGX) of Germany have announced an agreement…

AgennixBiotechnologyLonzaOncologyPharmaceuticalResearchtalactoferrin

Arrowhead takes over Alvos Thera in stock deal

12-04-2012

USA-based nano-medicine developer Arrowhead Research Corp (Nasdaq: ARWR) says it has acquired Alvos Therapeutics…

Alvos TherapeuticsArrowhead ResearchBiotechnologyMergers & AcquisitionsPharmaceutical

Amgen to snap up KAI Pharma for $315 million

11-04-2012

In a second acquisition announced so far this year, global biotech leader Amgen (Nasdaq: AMGN) said yesterday…

AmgenBiotechnologyKAI PharmaceuticalsMergers & AcquisitionsNephrology and Hepatology

iBio uses iBioLaunch technology to produce functional MAb copy of Synagis

11-04-2012

US biotech firm iBio (NYSE AMEX: IBIO) says that its proprietary iBioLaunch technology for the production…

AstraZenecaBiotechnologyiBIOMedImmunePalivizumabResearchRespiratory and PulmonarySynagis

GlaxoSmithKline links with Japan's Chiome on MAbs

10-04-2012

UK pharma giant GlaxoSmithKline group (LSE: GSK) and Tokyo, Japan-based biotech-venture company Chiome…

BiotechnologyChiome BioscienceGlaxoSmithKlineImmunologicalsLicensingOncologyPharmaceuticalResearch

Therapeutic MAbs market - Is biologics the answer to rising disease incidence?

10-04-2012

Existing adoption rates and commercial success of launched monoclonal antibodies (MAbs) for therapeutics…

BiotechnologyEuropeMarkets & MarketingResearch

Sanofi and Regeneron mCRC drug Zaltrap misses goals but gets FDA priority

10-04-2012

The US Food and Drug Administration has granted priority review of the Biologics License Application…

BiotechnologyNorth AmericaPharmaceuticalRegeneronRegulationResearchSanofiZaltrap

Investor Icahn slams Amylin for not revealing B-MS bid

05-04-2012

Billionaire US investor Carl Icahn has sent a blistering open letter to the board of US biotech company…

AmylinBiotechnologyBristol-Myers SquibbMergers & AcquisitionsPharmaceutical

EMA tightens conflicts-of-interests policies with immediate effect

04-04-2012

The European Medicines Agency yesterday published its updated policy on conflicts of interests of the…

BiotechnologyEuropePharmaceuticalRegulation

1930 to 1954 of 2293 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top